Logan TF - Search Results

1

Evidence for oligoclonal T-cell response in a metastasis of renal cell carcinoma responding to vaccination with autologous tumor cells and transfer of in vitro-sensitized vaccine-draining lymph node lymphocytes.

Weidmann E, Logan TF, Yasumura S, Kirkwood JM, Trucco M, Whiteside TL. Weidmann E, et al. Among authors: logan tf. Cancer Res. 1993 Oct 15;53(20):4745-9. Cancer Res. 1993. PMID: 8402652

2

Expression and activity of signaling molecules in T lymphocytes obtained from patients with metastatic melanoma before and after interleukin 2 therapy.

Rabinowich H, Banks M, Reichert TE, Logan TF, Kirkwood JM, Whiteside TL. Rabinowich H, et al. Among authors: logan tf. Clin Cancer Res. 1996 Aug;2(8):1263-74. Clin Cancer Res. 1996. PMID: 9816296

3

Inflammatory cell infiltrate in a responding metastatic nodule after vaccine-based immunotherapy.

Logan TF, Banner B, Rao U, Ernstoff MS, Wolmark N, Whiteside TL, Miketic L, Kirkwood JM. Logan TF, et al. Clin Exp Immunol. 1998 Dec;114(3):347-54. doi: 10.1046/j.1365-2249.1998.00731.x. Clin Exp Immunol. 1998. PMID: 9844042 Free PMC article.

4

MAGE-6 encodes HLA-DRbeta1*0401-presented epitopes recognized by CD4+ T cells from patients with melanoma or renal cell carcinoma.

Tatsumi T, Kierstead LS, Ranieri E, Gesualdo L, Schena FP, Finke JH, Bukowski RM, Brusic V, Sidney J, Sette A, Logan TF, Kasamon YL, Slingluff CL Jr, Kirkwood JM, Storkus WJ. Tatsumi T, et al. Among authors: logan tf. Clin Cancer Res. 2003 Mar;9(3):947-54. Clin Cancer Res. 2003. PMID: 12631591

5

NY-ESO-1 119-143 is a promiscuous major histocompatibility complex class II T-helper epitope recognized by Th1- and Th2-type tumor-reactive CD4+ T cells.

Zarour HM, Maillere B, Brusic V, Coval K, Williams E, Pouvelle-Moratille S, Castelli F, Land S, Bennouna J, Logan T, Kirkwood JM. Zarour HM, et al. Cancer Res. 2002 Jan 1;62(1):213-8. Cancer Res. 2002. PMID: 11782380

6

Plasminogen activator and its inhibitor in cancer patients treated with tumor necrosis factor.

Logan TF, Virji MA, Gooding WE, Bontempo FA, Ernstoff MS, Kirkwood JM. Logan TF, et al. J Natl Cancer Inst. 1992 Dec 2;84(23):1802-10. doi: 10.1093/jnci/84.23.1802. J Natl Cancer Inst. 1992. PMID: 1433370

7

Preparation of viable tumour cell vaccine from human solid tumours: relationship between tumour mass and cell yield. The Tissue Bank, Pittsburgh Cancer Institute.

Logan TF, Shannon W, Bryant J, Kane P, Wolmark N, Posner M, Kirkwood JM, Ernstoff MS, Futrell JW, Straw LD, et al. Logan TF, et al. Melanoma Res. 1993 Dec;3(6):451-5. doi: 10.1097/00008390-199311000-00008. Melanoma Res. 1993. PMID: 8161884

8

Biologic response modulation by tumor necrosis factor alpha (TNF alpha) in a phase Ib trial in cancer patients.

Logan TF, Gooding WE, Whiteside TL, Ernstoff MS, Kaplan SS, Miketic L, Vlock DR, Tompkins C, Wood DL, Nadler PI, Kirkwood JM. Logan TF, et al. J Immunother. 1997 Sep;20(5):387-98. doi: 10.1097/00002371-199709000-00008. J Immunother. 1997. PMID: 9336746 Clinical Trial.

9

Stereotactic radiosurgery for brain metastasis from renal cell carcinoma.

Mori Y, Kondziolka D, Flickinger JC, Logan T, Lunsford LD. Mori Y, et al. Cancer. 1998 Jul 15;83(2):344-53. doi: 10.1002/(sici)1097-0142(19980715)83:2<344::aid-cncr19>3.0.co;2-t. Cancer. 1998. PMID: 9669818

10

A phase 2, randomized study of SB-485232, rhIL-18, in patients with previously untreated metastatic melanoma.

Tarhini AA, Millward M, Mainwaring P, Kefford R, Logan T, Pavlick A, Kathman SJ, Laubscher KH, Dar MM, Kirkwood JM. Tarhini AA, et al. Cancer. 2009 Feb 15;115(4):859-68. doi: 10.1002/cncr.24100. Cancer. 2009. PMID: 19140204 Free article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

83 results

Search Page

Filters